Polypharmacy is associated with poor clinical outcomes following COVID-19 infection among patients with type 2 diabetes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results